Sodium taurodehydrocholate
| Catalog Number | BL-M000509 |
| CAS Number | 57011-24-2 |
| Description | Sodium taurodehydrocholate, a bile acid derivative, serves as a vital pharmaceutical component for managing hepatic and cholelithiasis afflictions. Frequently integrated into therapeutic regimens, it aims to ameliorate hepatic activity, deter gallstone formation, and facilitate digestive processes. |
 | |
| IUPAC Name | sodium;2-[[(4R)-4-[(5S,10S,13R,17R)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonate |
| Synonyms | Ethanesulfonic acid, 2-(((5beta)-3,7,12,24-tetraoxocholan-24-yl)amino)-, monosodium salt; Taurodehydrocholic acid, sodium salt; 5β-cholanic acid-3,7,12-trione N-(2-sulphoethyl)-amide, sodium salt |
| Molecular Weight | 531.64 |
| Molecular Formula | C26H38NNaO7S |
| Purity | >99% |
| Appearance | Powder |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 58.74%, H 7.20%, N 2.63%, Na 4.32%, O 21.07%, S 6.03% |
| Canonical SMILES | CC(CCC(=O)NCCS(=O)(=O)[O-])C1CCC2C1(C(=O)CC3C2C(=O)CC4C3(CCC(=O)C4)C)C.[Na+] |
| InChI | InChI=1S/C26H39NO7S.Na/c1-15(4-7-23(31)27-10-11-35(32,33)34)18-5-6-19-24-20(14-22(30)26(18,19)3)25(2)9-8-17(28)12-16(25)13-21(24)29;/h15-16,18-20,24H,4-14H2,1-3H3,(H,27,31)(H,32,33,34);/q;+1/p-1/t15-,16+,18-,19?,20?,24?,25+,26-;/m1./s1 |
| InChI Key | RKSAYDXINPFQGF-PFGONMSQSA-M |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry
